| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 12.42× | 12.42× | 12.38× | 11.43× | 10.65× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.47× | 1.80× | 2.86× | 1.68× | 2.44× | ||
| 1.00× | 1.00× | 1.02× | 0.96× | 0.99× | ||
| 0.71× | 0.71× | 0.81× | 1.23× | 0.50× | ||
| 0.58× | 0.58× | 0.61× | 0.91× | 0.35× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 10.65 | 11.43 | 12.38 | 12.42 | 12.42 | |
| Working Capital Turnover | 2.44 | 1.68 | 2.86 | 1.80 | 1.47 | |
| Asset Turnover | 0.99 | 0.96 | 1.02 | 1.00 | 1.00 | |
| Cash Conversion (CFO/Net Income) | 0.50 | 1.23 | 0.81 | 0.71 | 0.71 | |
| CFO/EBITDA | 0.35 | 0.91 | 0.61 | 0.58 | 0.58 |